BACKGROUND: Determination of the benefits and limitations of specific physiologic tests has not been well studied in long-term clinical pediatric trials. OBJECTIVE: We sought to determine the utility of impulse oscillometry in a long-term comparison of 3 controller regimens in children with persistent asthma. METHODS:Children 6 to 14 years of age with mild-to-moderate persistent asthma were characterized with oscillometry and spirometry before entry into a clinical trial and then serially during 48 weeks of therapy with either an inhaled corticosteroid, a combination inhaled corticosteroid with a long-acting beta-agonist, or a leukotriene receptor antagonist. RESULTS: The FEV(1)/forced vital capacity ratio, as well as the forced expiratory flow from 25% to 75% of forced vital capacity in terms of spirometric parameters and the reactance area (XA) from impulse oscillometry, appeared to complement information provided by FEV(1) when comparing the tests and factors that appeared to predict a response to treatment. XA was unique in that it, as distinct from spirometric variables, reflected ongoing improvement during the latter part of the trial. In general, improvements in XA during the latter part of the study occurred independently of indices of atopy and the level of airway responsiveness. CONCLUSION: Assessment of respiratory mechanics over time with oscillometry might offer additional insights into the response of asthmatic patients to therapy. In particular, the pattern of improvement seen in XA over the course of therapy suggests this test might detect alterations in airway mechanics not reflected by spirometry. The possibility that changes in XA reflect ongoing improvement in small airway function deserves additional study.
RCT Entities:
BACKGROUND: Determination of the benefits and limitations of specific physiologic tests has not been well studied in long-term clinical pediatric trials. OBJECTIVE: We sought to determine the utility of impulse oscillometry in a long-term comparison of 3 controller regimens in children with persistent asthma. METHODS:Children 6 to 14 years of age with mild-to-moderate persistent asthma were characterized with oscillometry and spirometry before entry into a clinical trial and then serially during 48 weeks of therapy with either an inhaled corticosteroid, a combination inhaled corticosteroid with a long-acting beta-agonist, or a leukotriene receptor antagonist. RESULTS: The FEV(1)/forced vital capacity ratio, as well as the forced expiratory flow from 25% to 75% of forced vital capacity in terms of spirometric parameters and the reactance area (XA) from impulse oscillometry, appeared to complement information provided by FEV(1) when comparing the tests and factors that appeared to predict a response to treatment. XA was unique in that it, as distinct from spirometric variables, reflected ongoing improvement during the latter part of the trial. In general, improvements in XA during the latter part of the study occurred independently of indices of atopy and the level of airway responsiveness. CONCLUSION: Assessment of respiratory mechanics over time with oscillometry might offer additional insights into the response of asthmatic patients to therapy. In particular, the pattern of improvement seen in XA over the course of therapy suggests this test might detect alterations in airway mechanics not reflected by spirometry. The possibility that changes in XA reflect ongoing improvement in small airway function deserves additional study.
Authors: H Eigen; H Bieler; D Grant; K Christoph; D Terrill; D K Heilman; W T Ambrosius; R S Tepper Journal: Am J Respir Crit Care Med Date: 2001-03 Impact factor: 21.405
Authors: R O Crapo; R Casaburi; A L Coates; P L Enright; J L Hankinson; C G Irvin; N R MacIntyre; R T McKay; J S Wanger; S D Anderson; D W Cockcroft; J E Fish; P J Sterk Journal: Am J Respir Crit Care Med Date: 2000-01 Impact factor: 21.405
Authors: Stanley J Szefler; Brenda R Phillips; Fernando D Martinez; Vernon M Chinchilli; Robert F Lemanske; Robert C Strunk; Robert S Zeiger; Gary Larsen; Joseph D Spahn; Leonard B Bacharier; Gordon R Bloomberg; Theresa W Guilbert; Gregory Heldt; Wayne J Morgan; Mark H Moss; Christine A Sorkness; Lynn M Taussig Journal: J Allergy Clin Immunol Date: 2005-02 Impact factor: 10.793
Authors: H Mitchell; Y Senturia; P Gergen; D Baker; C Joseph; K McNiff-Mortimer; H J Wedner; E Crain; P Eggleston; R Evans; M Kattan; C Kercsmar; F Leickly; F Malveaux; E Smartt; K Weiss Journal: Pediatr Pulmonol Date: 1997-10
Authors: Robert C Strunk; Stanley J Szefler; Brenda R Phillips; Robert S Zeiger; Vernon M Chinchilli; Gary Larsen; Kevin Hodgdon; Wayne Morgan; Christine A Sorkness; Robert F Lemanske Journal: J Allergy Clin Immunol Date: 2003-11 Impact factor: 10.793
Authors: Meyer Kattan; Leonard B Bacharier; George T O'Connor; Robyn Cohen; Ronald L Sorkness; Wayne Morgan; Peter J Gergen; Katy F Jaffee; Cynthia M Visness; Robert A Wood; Gordon R Bloomberg; Susan Doyle; Ryan Burton; James E Gern Journal: J Allergy Clin Immunol Pract Date: 2018-02-13
Authors: Erika G Meraz; Homer Nazeran; Carlos D Ramos; Pat Nava; Bill Diong; Michael D Goldman; Christine A Goldman Journal: Biomed Eng Online Date: 2011-03-25 Impact factor: 2.819
Authors: Hirsh D Komarow; Jeff Skinner; Michael Young; Donna Gaskins; Celeste Nelson; Peter J Gergen; Dean D Metcalfe Journal: Pediatr Pulmonol Date: 2011-08-24
Authors: Yixin Shi; Anna S Aledia; Ahramahzd V Tatavoosian; Shruthi Vijayalakshmi; Stanley P Galant; Steven C George Journal: J Allergy Clin Immunol Date: 2011-12-17 Impact factor: 10.793
Authors: Seyram Kaali; Darby W Jack; Rebecca K D Prah; Steven N Chillrud; Mohammed N Mujtaba; Patrick L Kinney; Theresa Tawiah; Qiang Yang; Felix B Oppong; Carlos F Gould; Musah Osei; Blair J Wylie; Oscar Agyei; Matthew S Perzanowski; Kwaku Poku Asante; Alison G Lee Journal: Pediatr Pulmonol Date: 2022-06-13
Authors: Nathan Rabinovitch; David T Mauger; Nichole Reisdorph; Ronina Covar; Jonathan Malka; Robert F Lemanske; Wayne J Morgan; Theresa W Guilbert; Robert S Zeiger; Leonard B Bacharier; Stanley J Szefler Journal: J Allergy Clin Immunol Date: 2013-09-29 Impact factor: 10.793